Trial Outcomes & Findings for Optimization of Hip-exoskeleton Weight Attributes (NCT NCT05120115)

NCT ID: NCT05120115

Last Updated: 2023-11-29

Results Overview

Amount of pelvic obliquity in response to weighted belt measured using optical motion capture

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

21 participants

Primary outcome timeframe

One day

Results posted on

2023-11-29

Participant Flow

Participant milestones

Participant milestones
Measure
Weight and Placement
Changing weights on belt at 0, 4, 6 and 8 kg (weight factor) and lumbar, bilateral or unilateral placement on pelvis (placement factor)
Overall Study
STARTED
21
Overall Study
no Weight
21
Overall Study
4kg and Bilateral Weight Distribution
21
Overall Study
6kg and Bilateral Weight Distriubtion
21
Overall Study
8 kg and Bilateral Weight Distriubtion
21
Overall Study
4 kg and Lumbar Weight Distriubtion
21
Overall Study
6kg and Lumbar Weight Distriubtion
21
Overall Study
8 kg and Lumbar Weight Distribution
21
Overall Study
4kg and Unilateral Weight Distribution
21
Overall Study
6kg and Unilateral Weight Distribution
21
Overall Study
8kg and Unilateral Weight Distribution
21
Overall Study
COMPLETED
21
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Optimization of Hip-exoskeleton Weight Attributes

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Weight and Placement
n=21 Participants
Changing where weight is distributed on belt around pelvis, specifically, bilaterally, 4th lumbar area, unilaterally on the left side. Also changing weight amounts at 4, 6 and 8 kg. Weight belt: Wearing belt around waist with various weights attached.
Age, Continuous
26.7 Years
STANDARD_DEVIATION 5.75 • n=5 Participants
Sex: Female, Male
Female
9 Participants
n=5 Participants
Sex: Female, Male
Male
12 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
20 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
5 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
Race (NIH/OMB)
White
15 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
21 participants
n=5 Participants
height
172 cm
STANDARD_DEVIATION 7.58 • n=5 Participants
weight
65.9 kg
STANDARD_DEVIATION 8.53 • n=5 Participants

PRIMARY outcome

Timeframe: One day

Population: Healthy individuals

Amount of pelvic obliquity in response to weighted belt measured using optical motion capture

Outcome measures

Outcome measures
Measure
Weight and Placement
n=21 Participants
Varying weight at 0, 4, 6 and 8 kg. Varying placement at bilateral, unilateral and lumbar areas of pelvis.
Pelvic Obliquity
No weight
-0.55 degrees
Standard Deviation 2.79
Pelvic Obliquity
4 kg and bilateral placement
-0.83 degrees
Standard Deviation 2.89
Pelvic Obliquity
6kg and unilateral weight distribution
-1.2 degrees
Standard Deviation 3.05
Pelvic Obliquity
8kg and unilateral weight distribution
-0.7 degrees
Standard Deviation 2.97
Pelvic Obliquity
4 kg and lumbar placement
-0.19 degrees
Standard Deviation 2.91
Pelvic Obliquity
6 kg and lumbar placement
0.08 degrees
Standard Deviation 2.93
Pelvic Obliquity
8kg and lumbar weight distribution
0.45 degrees
Standard Deviation 2.94
Pelvic Obliquity
4kg and unilateral
-0.76 degrees
Standard Deviation 2.98
Pelvic Obliquity
6kg and unilateral
-0.8 degrees
Standard Deviation 2.83
Pelvic Obliquity
8kg and unilateral
-1.15 degrees
Standard Deviation 2.77

SECONDARY outcome

Timeframe: One Day

Population: Healthy Individuals

Knee flexion angle range of motion measured using optical motion capture

Outcome measures

Outcome measures
Measure
Weight and Placement
n=21 Participants
Varying weight at 0, 4, 6 and 8 kg. Varying placement at bilateral, unilateral and lumbar areas of pelvis.
Knee Flexion Angle During Swing Phase
No weight
68.8 degrees
Standard Deviation 8.5
Knee Flexion Angle During Swing Phase
4 kg with bilateral
67.66 degrees
Standard Deviation 8.84
Knee Flexion Angle During Swing Phase
6 kg with bilateral
68.03 degrees
Standard Deviation 7.49
Knee Flexion Angle During Swing Phase
8 kg with bilateral
67.99 degrees
Standard Deviation 7.95
Knee Flexion Angle During Swing Phase
4 kg with lumbar
66 degrees
Standard Deviation 6.2
Knee Flexion Angle During Swing Phase
6kg with lumbar
66.13 degrees
Standard Deviation 7.01
Knee Flexion Angle During Swing Phase
8kg with lumbar
67.4 degrees
Standard Deviation 9.84
Knee Flexion Angle During Swing Phase
4kg with unilateral
68.41 degrees
Standard Deviation 8.09
Knee Flexion Angle During Swing Phase
6kg with unilateral
68.02 degrees
Standard Deviation 8.57
Knee Flexion Angle During Swing Phase
8kg with unilateral
66.23 degrees
Standard Deviation 6.72

SECONDARY outcome

Timeframe: One day

Population: Healthy Individuals

EMG signals were normalized via the mean-dynamic method (Burden and Bartlett, 1999), centering the EMG signal around 1. For data analysis, the EMG signal was integrated along each gait phase to calculate the integrated EMG (iEMG) values. For the gastrocnemius, we extrated the iEMG during the pre-swing phase only. The iEMG was normalized to average during walking, resulting in arbitrary units.

Outcome measures

Outcome measures
Measure
Weight and Placement
n=21 Participants
Varying weight at 0, 4, 6 and 8 kg. Varying placement at bilateral, unilateral and lumbar areas of pelvis.
Integrated Gastrocnemius Muscle Activity During Preswing Phase of Walking
No weight
1.16 arbitrary units
Standard Deviation 0.53
Integrated Gastrocnemius Muscle Activity During Preswing Phase of Walking
4 kg and bilateral
1.14 arbitrary units
Standard Deviation 0.48
Integrated Gastrocnemius Muscle Activity During Preswing Phase of Walking
6kg and bilateral
1.20 arbitrary units
Standard Deviation 0.55
Integrated Gastrocnemius Muscle Activity During Preswing Phase of Walking
8kg and bilateral
1.23 arbitrary units
Standard Deviation 0.53
Integrated Gastrocnemius Muscle Activity During Preswing Phase of Walking
4kg and lumbar
1.24 arbitrary units
Standard Deviation 0.66
Integrated Gastrocnemius Muscle Activity During Preswing Phase of Walking
6kg and lumbar
1.20 arbitrary units
Standard Deviation 0.54
Integrated Gastrocnemius Muscle Activity During Preswing Phase of Walking
8kg and lumbar
1.19 arbitrary units
Standard Deviation 0.56
Integrated Gastrocnemius Muscle Activity During Preswing Phase of Walking
4kg and unilateral
1.19 arbitrary units
Standard Deviation 0.49
Integrated Gastrocnemius Muscle Activity During Preswing Phase of Walking
6kg and unilateral
1.20 arbitrary units
Standard Deviation 0.51
Integrated Gastrocnemius Muscle Activity During Preswing Phase of Walking
8kg and unilateral
1.10 arbitrary units
Standard Deviation 0.43

Adverse Events

Weight and Placement

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

James Sulzer

MetroHealth Hospital

Phone: 5125419036

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place